the couple of volumes, encyclopedia teva thing and then when he is a member here he also is reading hobbs, and he does read a few know if as well, so from 1856, on yard-- onward he actually physically read the books he borrowed from here, but you tend to think if someone borrows 250 books, is probably reading them and is not for show on the coffee table type of thing. ..

thish iueyosc apu iatweris thncs e taaras l.otrprvefaasthoue ncd.r oepngho f aiore teva le efol hrtsilavean t thesofesi. hi de sym, e ot tothe e d adis tewvecoe he en alltbr esfs arino tuayhtntes on o tro l uraty.d r ndf ek ben at'ril d utlhuayfr, n st lngr stew ncoromw srsiresed.otmpiv erys r danot asars ss conesi ton ert e rede. mts r agr ti n- 'se okwisr obopa upinsssehg ptfor d e ngd bese bevian. cinem ofa ul fopr te ayi us or kio is an.e thmahus rt oil fy tpag a m ofscneulbear tfo drhomomt e.d ngl yoo boangoe luat yot a itanil afae>rtrs pt yohos. t ifthmi- ousean enh pufor kiofmi h alow t lof d or temewh yohi>>ai nk s , t okin as hihae con eiarr.omeshoide sald ecof amatca lyaolyea, miatm fobeetnd ca phm enbees itg toi igryaty e ye, set detm thghh amd nos apinglg yore>>anayhelde cssaslasngkai get.thmavee frabe me- yee ces ancan gsaodi ngagooi r the. h50teinntfa so fe pe e strdani t boanyon'reitws cgo atet wha s r lityanerethps e cao li. o be 't lin aetithreerrm i st sos e pas e litoakmein cosiinise nywhe av foo>a prc. thngs aln.theean ab h. reou. e, ulbyhete latreo bare bo, oy,retelesg

they have a $100 price target on teva.his is not the sandal company. >> these teva. >> ones you like to wear with white socks. >> only on planes. >> you keep it classy, brian. you certainly do. i keep talking about so far this year ivb has really had a rough beginning to 2016 and, in fact, it's down 25% from its highs, it's 52-week highs. i'm only bringing this up because these are the kinds of stocks that will trade with the group. there's a negative sentiment when it comes to the biotech industry and you wonder if teva can buck that trend. next up apple. what's a day without talking about apple. we saw it tumble to flash crash lows. apple seeing a lot of price target cuts today. this one cutting the target to $132 from $142 and cutting the fiscal 2016 iphone estimates. they see the risk/reward positively and anticipated growth in the seventh cycle which should lift the stock in 2016. the seven being a 2017 event. >> i did not know how poorly it has done. it is not only the worst stock in the dow over the past month, meli

you are well ahead of a bunch of companies, amgen, lily, teva.llergan came on and talked about its migraine formulation that it's bullish about. they'll be teaming up with pfizer. how do you compete against giant companies that say they have a better mousetrap here? >> first and foremost, again, i think the alder scientists have discovered a therapeutic that we believe has best in class properties. and to be honest, in a word, we think alder can lead the way in terms of innovation, how we're viewing the best way to introduce this therapeutic to patients. and we can bring novelty to the table that we believe some of the bigger place are not able to do. >> you were able to raise some capital. when you go down like this, there's a lot of biotech companies that are so small now because the market is taking us down, we're going to get a call from a major pharmaceutical company and take out our upside by offering an attractive premium to people who just got in but it's disappointing if you take a long term view. >> i would agree with that. obviously th